http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
유재영(Jae Young Yoo),신호균(Ho Kyun shin),고순희(Soon Hee Koh),김종혁(Jong Hyouk Kim),송숙희(Sook Hee Song),김규태(Kyu Tae Kim),김학양(Ho Kyun Shin),김진한(Jin Han Kim) 대한소화기학회 1990 대한소화기학회지 Vol.22 No.4
Primary biliary cirrhosis is a relatively common liver disease with cholestasis in Western countries, especially in the middle aged women. The sex distributian of this disease between male to female was 1/9. 1n the Korean literatures, there were only 4 casea reported in female, not in male. We report a case of primary biliary cirrhosis with a review of literatures in a 62-year-old man whose serum bilirubin and alkaline phosphatase were persistently elevated.
간장 및 담도 : 만성 B형 간질환 환자에서 각종 바이러스 증식 표지자의 출현동태
유재영(Jae Young Yoo),박충기(Choong Kee Park),김우중(Woo Joong Kim),김태빈(Tae Bin Kim),고순희(Soon Hee Koh),계세협(Sea Hyub Kae),신효균(Ho Kyun Shin),김연근(Yeon Keun Kim),임규성(Kyu Sung Lim) 대한소화기학회 1990 대한소화기학회지 Vol.22 No.1
N/A We studied several viral replication markers of hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma to evaluate the clinical significance of thesemarkers in serum. The patients comprised of 43 males and 8 females, and ages from 17 to 64 (mean: 34) years. All patients were sero-positive for hepatitis B surface antigen (HBsAg). Histologically, 36 patients showed chronic active hepatitis and 15 showed hepatocellular carcinoma. The viral replication markers tested were hepatitis B e antigen (HBeAg), antibody to hepatitis B e antigen (anti-HBe), Immunoglobulin M antibody to hepatitis B core antigen (IgM anti-HBc), DNA polymerase and hepatitis B virus deoxyribonucleic acid (HBV-DNA). The results were summerized as follows. 1) The younger the patients, the higher was the positive rate of HBeAg; the older the patients, the higher was the positive rate of anti-HBe. 2) There was a reverse correlation between the age and the level of serum alanine aminotransferase (ALT); the younger the patients, the higher was the titer. But no correlation was noted between age and the level of serum aspartate aminotransferase (AST). 3) The histologic findings of the liver tended to be more severe in older patients. The patients with hepatocellular carcinoma were the oldest group. 4) The positive rate of HBeAg was higher in patients with chronic hepatitis than in patients with hepatocellular carcinoma. but there was no difference between these two groups in the positive rate of IgM anti-HBc. 5) The positive rate of HBV-DNA and DNA polymerase was 63% and 35%, respectively, and their titers were significantly low. 6) There was no significant correlation between the positive rate of HBeAg, IgM anti-HBc, HBV-DNA, and DNA polymtrase. On the basis of these findings, it is suggested that the natural history of chronic hepatitis B of Koreans might be different from that of Caucasians; the positive rate and the titers of the viral replication markers were lower in Koreans.
관동맥 질환 환자에서 Lipoprotein ( a ) 농도와 당내인성과 관련성
두영철(Young Cheoul Doo),최조영(Jo Young Choi),장명국(Myung Kuk Jang),홍성훈(Sung Hun Hong),장명준(Myeong Jun Chang),고순희(Soon Hee Koh),한규록(Kyoo Rok Han),오동진(Dong Jin Oh),유규형(Kyu Hyung Ryu),고영박(Young Bahk Koh),이영(You 대한내과학회 1996 대한내과학회지 Vol.51 No.4
Objectives: A raised Lp (a) lipoprotein concentration is associated with coronary artery disease and impaired glucose intolerance has also been shown to be predictive of coronary artery clisease in some studies. It has been suggested that there is a significant association between impaired glucose tolerance and increased circulating Lp (a) lipoprotein concentration. The object of this study is to determine whether glucose intolerance and raised Lp (a) concentration are associated in subjects with coronary artery disease. Methods: The study group comprised 60 patients with coronary artery disease (M:20, mean age 56+/-13 year) and 70 control subjects without coronary artery disease (M:15, mean age 58+/-10 year). We compared the clinical variables, lipid profile including Lp (a), fasting glucose, and fasting insulin in subjects with coronary artery disease with impaired glucose tolerance and normal glucose tolerance, and in controls. Results: 1) Nine of 60 patients (15%) with coronary artery disease had glucose intolerance. There were no significant difference in the incidence of cardiovascular risk factors, body mass index, left ventricular mass index, the levels of lipid including Lp (a), and the levels of fasting glucose, insulin, and C-peptide except in the incidence of smoking (48% in patients with coronary artery disease vs 24% in normal control, p<0.05) between patients with coronary artery disease and normal controls. 2) Between coronary artery disease patients group with and without glucose intolerance, and normal controls, there were no difference in the level of Lp (a) concentration. Conclusion: The level of fasting glucose and concentration of Lp (a) were no difference in between patients with coronary artery disease and normal controls. There was no difference in concentration of Lp (a) in patients of coronary artery disease with and without glucose intolerance, and so suggest that raised Lp (a) lipoprotein concentration are not responsible for the association between impaired glucose tolerance and coronary artery disease.